Seeing the MMP-9 inhibitors applied to thyroid cancer, we find that these kinds of inhibitory molecules get involved in a series of critical steps in the tumor progression, for instance, in proliferation, migration, invasion, metastasis, angiogenesis, apoptosis, redifferentiation and epithelial-mesenchymal transition (EMT). This evidence concerns the gene MMP9 and thyroid gland carcinoma.